- Alcohol Deterrents Clinical Trials
- Analgesics, Narcotic Clinical Trials
- Analgesics, Non-narcotic Clinical Trials
- Anti-allergic Agents Clinical Trials
- Anti-arrhythmia Agents Clinical Trials
- Anti-dyskinesia Agents Clinical Trials
- Anti-infective Agents Clinical Trials
- Anti-inflammatory Agents Clinical Trials
- Anti-obesity Agents Clinical Trials
- Anticoagulants Clinical Trials
- Anticonvulsants Clinical Trials
- Antiemetics Clinical Trials
- Antihypertensive Agents Clinical Trials
- Antilipemic Agents Clinical Trials
- Antineoplastic Agents Clinical Trials
- Antisickling Agents Clinical Trials
- Antitussive Agents Clinical Trials
- Blood Substitutes Clinical Trials
- Bone Density Conservation Agents Clinical Trials
- Cardiotonic Agents Clinical Trials
- Central Nervous System Stimulants Clinical Trials
- Channel Blockers Clinical Trials
- Coagulants Clinical Trials
- Dermatologic Agents Clinical Trials
- Fibrinolytic Agents Clinical Trials
- Gastrointestinal Agents Clinical Trials
- Hematinics Clinical Trials
- Hypnotics And Sedatives Clinical Trials
- Hypoglycemic Agents Clinical Trials
- Micronutrients Clinical Trials
- Muscle Relaxants, Central Clinical Trials
- Narcotic Antagonists Clinical Trials
- Natriuretic Agents Clinical Trials
- Neuroprotective Agents Clinical Trials
- Nitric Oxide Donors Clinical Trials
- Nootropic Agents Clinical Trials
- Ntral Nervous System Depressants Clinical Trials
- Platelet Aggregation Inhibitors Clinical Trials
- Psychotropic Drugs Clinical Trials
- Renal Agents Clinical Trials
- Reproductive Control Agents Clinical Trials
- Respiratory System Agents Clinical Trials
- Rheumatic Agents Clinical Trials
- Vasoconstrictor Agents Clinical Trials
- Vasodilator Agents Clinical Trials
Gatifloxacin Clinical Trials
Listings Sponsored By:
Evaluation of efficacy of topical preoperative antibiotics in patients undergoing intravitreous injections.
Status: Recruiting Start Date: Completion Date:
The objective of this study is to evaluate the safety and efficacy of Besivance (besifloxacin 0.6%) ophthalmic suspension compared to gatifloxacin 0.3% ophthalmic solution when administered three times daily (TID) for seven days to neonatal subjects who are 31 [more...] days or younger on the day of randomization (Visit 1).
Status: Recruiting Start Date: April 2011 Completion Date: July 2013
The purpose of this study is a prospective,double-blinded, randomized trial to compare the rate of healing following PRK after the use of two commercially available 4th generation fluoroquinolones, moxifloxacin and gatifloxacin.
Status: Completed Start Date: Completion Date:
The purpose of this study is to compare patient outcomes in following cataract surgery in patients randomized to one of two surgical kits.
Status: Completed Start Date: Completion Date:
This is a 7 day study to evaluate the safety and efficacy of topical gatifloxacin ophthalmic solution for the treatment of bacterial conjunctivitis in subjects from birth to 31 days of age
Status: Completed Start Date: June 2007 Completion Date: September 2008
The purpose of this study is to assess the concentration of besifloxacin compared to gatifloxacin and moxifloxacin in human conjunctival tissue, following a single drop of the drug instilled topically into the study eye. Conjunctival biopsies will be performed at [more...] specified time points, followed by the use of loteprednol etabonate/tobramycin ophthalmic suspension four times a day for 5 days.
Status: Completed Start Date: March 2009 Completion Date: April 2009
This study is being conducted to assess the concentration of besifloxacin, moxifloxacin, or gatifloxacin in aqueous humor samples collected following topical instillation of the associated formulation in subjects undergoing cataract surgery.
Status: Completed Start Date: February 2009 Completion Date: August 2009
This study will evaluate the ability of 4 antibiotics to kill the bacteria that cause tuberculosis (TB). The antibiotics to be studied are linezolid, gatifloxacin, levofloxacin, and moxifloxacin. All are approved by the Brazilian health authorities to treat infections [more...] caused by germs other than TB. Seventy human immunodeficiency virus (HIV)-negative adults, aged 18-65 years, who have been newly diagnosed with pulmonary (lung) TB, will participate in this study. Study volunteers will be given one of the 4 study drugs or a comparison antibiotic, Isoniazid, which has been used around the world as a standard of care treatment for TB. Volunteers will stay in the hospital for 10 days and be given a study antibiotic 7 of those days. Blood and saliva samples will be taken. Six weeks later, volunteers will return for a final health check. All volunteers will receive 6 months of standard tuberculosis treatment.
Status: Completed Start Date: February 2004 Completion Date: December 2007
Clinical trials allow volunteers access to medical treatment options before they are available to the general public. Participants often receive the best healthcare available for their condition.
Risks are a reality, however, and may include more frequent doctor visits, health risks (possibly life-threatening), and/or the treatment being ineffective. Trials are federally regulated with strict guidelines to protect participants.
Gatifloxacin Clinical Trials Information presented on ClinicalTrialsSearch.org is not intended to be a substitute for qualified medical advice visit or treatment with a real physician. We are not physicians. Always consult with a medical doctor (MD). ClinicalTrialsSearch.org is a website dedicated to listing clinical research studies in human subjects, including those specifically related to Gatifloxacin. Clinical research trials and medical trials take place in hundreds of cities across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the effectiveness of new treatments and drugs. The purpose of the studies is to answer specific human health questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies to find treatments for all kinds of conditions. Clinical trials allow volunteers access to medical treatment options before they are available to the general public. Many times the participants receive treatment for free, and sometimes they are paid for their time. Participants often receive the best healthcare available possible for their condition. Risks are a reality, however, and may include more frequent doctor visits, health risks (possibly life-threatening), and/or the treatment being ineffective. U.S. - based Gatifloxacin studies are federally regulated with strict guidelines to protect patients.
There are a number of clinical trials underway to find effective treatments for diabetes, including new drugs, surgery and even transplantation.
There are several current and ongoing trials of interventions for major depressive disorder, which is characterized by a disabling combination of symptoms causing severe disruption to the sufferer's ability to carry out routine functions and tasks of daily life.
Constipation is a illness where the bowels cannot move waste material out of the body in a normal manner. There are various clinical trials recruiting participants to study the effectiveness of various treatments.